Commodity Trading & Distribution company Swan Corp announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 86,965.31 lakh, reflecting an increase of 1.62% YoY compared to Rs 85,575.29 lakh in Q4FY25. On a QoQ basis, it decreased by 24.38% from Rs 1,15,001.56 lakh in Q3FY26. For FY26, total revenue was Rs 4,37,119.56 lakh, marking a drop of 11.48% YoY against Rs 4,93,786.86 lakh in FY25. Total Income: Reached Rs 1,50,858.39 lakh in Q4FY26, up significantly by 71.04% YoY from Rs 88,203.35 lakh in Q4FY25, and an increase of 28.12% QoQ from Rs 1,17,749.64 lakh in Q3FY26. For FY26, total income was Rs 5,14,351.46 lakh, down by 25.28% YoY from Rs 6,88,368.03 lakh in FY25. Net Profit/(Loss) After Tax: The company posted a strong net profit of Rs 25,132.58 lakh in Q4FY26, showing a successful turnaround from a net loss of Rs 2,234.69 lakh in Q4FY25 and a net loss of Rs 118.02 lakh in Q3FY26. For FY26, the net profit stood at Rs 27,128.10 lakh, a decline of 68.98% YoY compared to Rs 87,440.51 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, revenue was Rs 5,314.84 lakh, registering a 25.58% YoY growth from Rs 4,232.34 lakh in Q4FY25. However, it saw an 11.67% QoQ decline from Rs 6,016.77 lakh in Q3FY26. For FY26, revenue increased by 59.46% YoY to Rs 21,601.17 lakh from Rs 13,546.33 lakh in FY25. Total Income: Reported at Rs 8,454.40 lakh in Q4FY26, jumping by 62.33% YoY from Rs 5,208.13 lakh in Q4FY25, and up 24.97% QoQ from Rs 6,765.21 lakh in Q3FY26. For FY26, total income grew by 67.40% YoY to Rs 28,446.96 lakh from Rs 16,993.45 lakh in FY25. Net Profit/(Loss) After Tax: Surged massively to Rs 1,205.15 lakh in Q4FY26, an increase of 299.36% YoY from Rs 301.77 lakh in Q4FY25, and up by 443.45% QoQ from Rs 221.76 lakh in Q3FY26. For FY26, net profit reached Rs 2,759.66 lakh, up by 204.77% YoY compared to Rs 905.49 lakh in FY25. Business Highlights: Segment-wise Performance: Textile: Revenue for Q4FY26 was Rs 5,291.97 lakh, growing 35.07% YoY. For FY26, it reached Rs 20,682.78 lakh, marking a solid 82.75% YoY increase. Construction/Others: Revenue stood at Rs 1,522.28 lakh in Q4FY26 (down 37.52% YoY). FY26 revenue was Rs 12,577.59 lakh, slightly up by 3.64% YoY. Distribution & Development: The segment recorded a revenue of Rs 54,372.54 lakh in Q4FY26 (down 29.04% YoY). Full-year FY26 revenue was Rs 3,68,990.66 lakh, a 12.37% YoY decline. Warehousing: Q4FY26 revenue was Rs 2,150.73 lakh (up 2.00% YoY). FY26 revenue stood at Rs 6,654.66 lakh, dropping by 36.40% YoY. Shipyard: Displayed massive growth with Q4FY26 revenue of Rs 23,627.79 lakh, compared to just Rs 491.24 lakh in Q4FY25. FY26 revenue also leaped exponentially to Rs 28,213.87 lakh from Rs 703.46 lakh in FY25. Energy: The segment reported nil revenue for FY26 compared to Rs 38,103.52 lakh in FY25. Dividend Recommendation: The Board of Directors has recommended a dividend of Re 0.15/- (Fifteen Paise only) per equity share of face value Re 1/- each (15%) for FY26, subject to shareholder approval. Corporate Appointments: Mr. Sugavanam Padmanabhan has been re-appointed as Whole-Time Director for a further term of three years, commencing from September 24, 2026. Additionally, M/s. Nisha Patel & Associates was appointed as Cost Auditor, and Mr. Narendra Vala was appointed as Internal Auditor for FY27. AGM & Record Date: The 118th Annual General Meeting (AGM) is scheduled to be held on September 04, 2026. The Board has fixed August 28, 2026, as the Record Date for determining dividend entitlement. Result PDF
Biotechnology company Concord Biotech announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 32,607.96 lakh, registering a decline of 24.15% YoY compared to Rs 42,988.38 lakh in Q4FY25. However, it witnessed an increase of 17.39% QoQ from Rs 27,776.60 lakh in Q3FY26. For FY26, revenue was Rs 1,05,489.07 lakh, reflecting a 12.10% YoY drop against Rs 1,20,008.69 lakh in FY25. Total Income: Q4FY26 total income reached Rs 34,142.90 lakh, marking a 22.27% YoY decrease from Rs 43,926.78 lakh in Q4FY25, but an 18.66% QoQ growth compared to Rs 28,774.22 lakh in Q3FY26. For FY26, total income stood at Rs 1,10,724.60 lakh, representing a decline of 11.03% YoY from Rs 1,24,453.36 lakh in FY25. Profit After Tax (Net Profit): The net profit for Q4FY26 was Rs 8,846.70 lakh, declining by 36.98% YoY compared to Rs 14,038.72 lakh in Q4FY25, while showing a strong 39.01% QoQ recovery from Rs 6,364.15 lakh in Q3FY26. For FY26, net profit was Rs 25,922.91 lakh, dropping by 30.25% YoY from Rs 37,164.23 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: Standalone revenue for Q4FY26 was Rs 32,589.20 lakh, down by 24.19% YoY from Rs 42,988.38 lakh in Q4FY25, and up by 17.17% QoQ from Rs 27,813.39 lakh in Q3FY26. For FY26, revenue decreased by 12.08% YoY to Rs 1,05,507.10 lakh from Rs 1,20,008.69 lakh in FY25. Total Income: For Q4FY26, total income stood at Rs 34,143.37 lakh, a decline of 22.27% YoY from Rs 43,926.78 lakh in Q4FY25, but an increase of 18.46% QoQ from Rs 28,821.61 lakh in Q3FY26. For FY26, total income reached Rs 1,10,780.16 lakh, falling by 10.99% YoY against Rs 1,24,453.36 lakh in FY25. Profit After Tax (Net Profit): Standalone net profit for Q4FY26 was recorded at Rs 9,002.21 lakh, dropping by 36.58% YoY compared to Rs 14,193.76 lakh in Q4FY25, and improving by 32.81% QoQ from Rs 6,778.27 lakh in Q3FY26. For FY26, net profit was Rs 26,326.67 lakh, down by 29.41% YoY from Rs 37,296.44 lakh in FY25. Business Highlights: Dividend Recommendation: The Board of Directors has recommended a dividend of Rs 7.55 per equity share of face value of Re 1 each fully paid up for the financial year 2025-26, subject to shareholder approval. Acquisition: Concord Biotech Limited acquired Celliimune Biotech Private Limited on April 2, 2026. The company invested Rs 1.2 lakh for the acquisition of shares out of a total consideration of Rs 66 lakh, making Celliimune Biotech Private Limited a wholly-owned subsidiary. Exceptional Item (Statutory Impact): The company recognized an incremental liability of Rs 327.54 lakh towards employee benefit obligations, primarily arising from the revised definition of wages under the New Labour Codes notified by the Government of India. This has been disclosed under exceptional items. Result PDF